Hope you're having a good time at Health Optimisation Summit 2026!
Would you like earn ROI of the rapid-growing Longevity industry?
You're at the right place!
What is L Cell?
L Cell is a growth-phase startup that develops, manufactures and sells innovative Longevity nutraceuticals.
Our R&D & manufacturing is located in Lithuania, but we're selling worldwide.
Our main field of interest are Senolytics (such as Fisetin), NAD+ boosters (such as NMN), Autophagy Modulators (such as Spermidine) and Antioxidants (such as GlyNAC), which all play a major part in slowing down the epigenetic mutation and cell senescence.
To the moon!
Starting from 0, in 2025 our sales grew 7 times to £700k and in 2026 we're estimating at least £1.5M yearly revenue.
Our goal is to reach £100M revenue by 2030.
Roughly 60% of our sales come from E-commerce and 40% from Distribution to pharmacies and health stores.
Some numbers
20%
Average EBITDA
£4M
Company evaluation at this point (September 2026)
15
Employees (R&D + Production + Management)
350+
Physical retail locations
20.000+
E-commerce customers worldwide
4.9*
Trustpilot rating
Our Story
L Cell was established in 2024 when our co-founders (Rokas & Vladas) met an epigenetics scientist (Dr. Mindaugas Valius), who is particularly interested in cell senescence pathways.
As Rokas & Vladas were already developing & manufacturing other dietary supplements in their lab, they could promptly test & launch new longevity nutraceuticals formulas, based on Mindaugas' expertise.
Starting from 0, we grew rapidly and now sell to over 30 countries.
Even though we've attracted an early-stage private investor Hinde, the growth comes mainly from bootstrapping.
Now we are looking for a new phase of growth - conducting clinical trials for our unique formulas and conquering new markets.
Would you like to join the journey?
What are our next steps for product development?
#1 Pure ingredients
We initially started by offering pure ingredient formulas. Our goal was to offer a complete longevity stack to longevity enthusiasts. No additives or lies - just premium quality ingredients in high dosages.
#2 Complete Formulas
Then together with biochemistry scientists we identified the most promising ingredients for specific purposes and combined them to complete formulas. They are now our bestsellers.
#3 Clinical trials
In 2027 we are planning to start a series of clinical trials for our different purpose formulas (senescence, energy, brain activity, metabolism and other).
Meet our management
Dr. Mindaugas Valius
Mindaugas is the Head of the Proteomics Centreand a dedicated longevity enthusiast. He has been exploring genome and epigenome behaviour at the cellular level since 1984 and has published over 100 scientific articles in this field.
Hinde is not only a private investor based in the UAE, but also a true innovator in the longevity space. She actively practises the latest longevity routines herself—and the results speak for themselves, as she looks remarkably youthful for her age.
